AU2018904159A0 - Extended Release Formulation - Google Patents

Extended Release Formulation

Info

Publication number
AU2018904159A0
AU2018904159A0 AU2018904159A AU2018904159A AU2018904159A0 AU 2018904159 A0 AU2018904159 A0 AU 2018904159A0 AU 2018904159 A AU2018904159 A AU 2018904159A AU 2018904159 A AU2018904159 A AU 2018904159A AU 2018904159 A0 AU2018904159 A0 AU 2018904159A0
Authority
AU
Australia
Prior art keywords
release formulation
extended release
formulation
extended
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018904159A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimerix Bioscience Pty Ltd
Original Assignee
Dimerix Bioscience Pty Ltd
Filing date
Publication date
Application filed by Dimerix Bioscience Pty Ltd filed Critical Dimerix Bioscience Pty Ltd
Publication of AU2018904159A0 publication Critical patent/AU2018904159A0/en
Abandoned legal-status Critical Current

Links

AU2018904159A 2018-11-01 Extended Release Formulation Abandoned AU2018904159A0 (en)

Publications (1)

Publication Number Publication Date
AU2018904159A0 true AU2018904159A0 (en) 2018-11-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP3582755A4 (en) Formulations
EP3645629A4 (en) Irradiation-curable polyolefin formulation
EP3722498A4 (en) Soil release agent
GB201801614D0 (en) Formulation
GB201817867D0 (en) Aerosolisable formulation
GB201817865D0 (en) Aerosolisable formulation
EP3895891A4 (en) Release film
GB201817859D0 (en) Aerosolisable formulation
EP4072553A4 (en) Cariprazine release formulations
GB201817862D0 (en) Aerosolisable formulation
GB201816447D0 (en) Formulation
EP3584076A4 (en) Release film
EP3600279A4 (en) 1-amino-1-cyclopropanecaboxylic acid formulations
EP3711763A4 (en) Controlled release formulation
EP3716766A4 (en) Benzoxaborole compounds and formulations thereof
GB201817864D0 (en) Aerosolisable formulation
GB201817863D0 (en) Aerosolisable formulation
EP3718537A4 (en) Disease-site-specific liposomal formulation
EP3946296A4 (en) Extended release pharmaceutical formulation
EP3773484A4 (en) Carmustine formulation
GB201807312D0 (en) Formulation
EP3582748A4 (en) Sulfate-free formulations
EP4084607A4 (en) Extended release plastic formulation
IL280138A (en) Aerosolisable formulation
EP3831399A4 (en) Anti-norovirus agent